Differential compensation mechanisms define resistance to PI3K inhibitors in PIK3CA amplified HNSCC

Abstract

This study suggests that inhibition of the PI3K and Ras-MEK-ERK pathways might be effective in some HNSCC patients; however, it also prompts the study of additional resistance mechanisms to identify synergistic combination therapies for tumors resistant to these di-therapies.